Skip to main content
Equibles

Samuel J. Sears

Board Member

Inhibitor Therapeutics, Inc. (INTI)

Equibles does not estimate personal net worth.

Get an email with a short summary when Inhibitor Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get INTI alerts

About Samuel J. Sears

Samuel J. Sears is recorded as Board Member at Inhibitor Therapeutics, Inc. (INTI) since September 15, 2026. Inhibitor Therapeutics, Inc. reported in an 8-K filed September 18, 2026 that Samuel J. Sears was appointed Director, effective September 15, 2026. Inhibitor Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inhibitor Therapeutics, Inc. includes Francis E. O'Donnell (CEO and Board Member), Francis E. O'Donnell, Jr. (CEO and Chairman), Francis E. O'Donnell, Jr., M.D. (CEO and Chairman) and 7 others.

“Francis E. O'Donnell, Samuel J. Sears, Niraj Vasisht, Michelle Yanez, Michael Jerman and Ronald E. Osman were each elected to serve on the Board of Directors (the "Board") for a one-year term that expires at the 2027 Annual Meeting of Stockholders, or until their earlier death, resignation or removal and their successors are elected and qualified.”
Inhibitor Therapeutics, Inc. Form 8-K, filed September 18, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Inhibitor Therapeutics, Inc.

Recent activity